A new skincare trend is circulating on social media, fueled by videos on platforms like TikTok and Instagram: using vaginal estrogen cream on the face. Proponents claim the cream can reduce wrinkles, dryness, and sagging skin, essentially acting as a DIY filler. But dermatologists and other medical experts are sounding the alarm, cautioning against this off-label use due to a lack of scientific evidence and potential health risks. The core issue? Vaginal estrogen is formulated and approved for a very specific purpose – addressing genitourinary symptoms related to menopause – and its application to facial skin introduces a host of unknowns.
The appeal is understandable. Estrogen plays a vital role in skin health, stimulating collagen production, increasing hyaluronic acid for hydration, and enhancing elasticity. As estrogen levels decline with age, particularly during menopause, skin can become thinner, drier, and more prone to wrinkles. This biological connection is what drives the logic behind the trend, as explained by Dr. Adam Friedman, professor and chair of dermatology at the George Washington University school of medicine and health sciences. “The biology makes sense, so the concept isn’t coming from nowhere,” he says. However, logic doesn’t equate to safety or efficacy.
Dr. Oma Agbai, associate clinical professor of dermatology at the University of California Davis School of Medicine, confirms she’s seeing patients inquire about the practice. “Patients are definitely asking about this, usually after seeing videos on TikTok or Instagram,” she says. While some report subjective improvements in skin texture, experts emphasize that these anecdotal experiences don’t constitute proof of benefit. The Food and Drug Administration (FDA) has not approved vaginal estrogen creams for any use other than vaginal application, and the American Academy of Dermatology does not recommend them as a facial treatment. “Using vaginal estrogen on the face or body is not evidence-based and not something I recommend,” Agbai states firmly.
Why Off-Label Use Raises Concerns
The practice of using medications “off-label” – for a purpose other than what they were originally approved for – is not uncommon in medicine. However, it’s typically done under the careful supervision of a physician, based on a thorough understanding of the potential benefits and risks. Self-treating with vaginal estrogen on the face falls far outside this framework. The primary concern revolves around systemic absorption – the possibility of the estrogen being absorbed into the bloodstream.
“It’s possible for topical estrogen to circulate to other areas of the body via the bloodstream, especially when used on large surface areas, thin skin, or over long periods of time,” Agbai explains. This systemic absorption raises concerns about hormonal side effects, such as breast tenderness or abnormal bleeding. More seriously, it could pose theoretical risks for individuals with estrogen-sensitive conditions like breast, ovarian, or endometrial cancer. The FDA’s prescribing information for estradiol vaginal cream explicitly acknowledges that systemic absorption can occur, as noted by Dr. Friedman. Research published in the National Center for Biotechnology Information further supports this potential for systemic absorption.
While absorption is likely minimal with small applications to the face, the risk increases significantly with larger areas, such as the abdomen, thighs, or buttocks. Dr. Maral Skelsey, clinical professor of dermatology at Georgetown University’s school of medicine and director of the Dermatologic Surgery Center of Washington, cautions, “We really don’t know how and where to use it and what it’s going to do.”
Limited Research, Varying Opinions
Despite the theoretical basis for the trend, robust scientific evidence supporting the use of vaginal estrogen as a facial treatment is lacking. A 1994 study, cited by Dr. Friedman, showed that conjugated estrogen (Premarin) cream applied nightly for 24 weeks led to increased skin thickness and improved wrinkles compared to a placebo. Similarly, a 2008 study published in JAMA Dermatology found that topical estradiol increased collagen content in abdominal and hip skin. However, Friedman emphasizes that this data is “limited, heterogeneous, and not a green light for do-it-yourself repurposing of genital formulations.”
Opinions among dermatologists are nuanced. Dr. Ellen Gendler, a cosmetic dermatologist at NYU Langone medical center, acknowledges that a tiny amount of vaginal estrogen cream around the eyes might not be harmful, and she herself uses it sparingly in that area. She attributes this to the skin-thickening effects of estrogen, which she’s observed over decades of clinical practice. However, she strongly advises against applying it to the entire face or other body areas.
Safer, Evidence-Based Alternatives
Fortunately, a wealth of well-studied and safe alternatives exist for improving skin health and addressing signs of aging. Dermatologists recommend proven strategies like prescription topical retinoids, daily broad-spectrum sunscreen, topical antioxidants (such as vitamin C serum), barrier-repair moisturizers, and in-office treatments like lasers, microneedling, and injectables. These options have undergone rigorous testing and have a much clearer safety profile.
It’s important to distinguish these from estrogen-infused face creams, which are available both over-the-counter and by prescription. Agbai notes that these creams are formulated specifically for facial use and may be considered under medical supervision, but they are not typically first-line treatments and are not suitable for everyone, particularly those with hormone-sensitive cancer risks.
the consensus among experts is clear: while the idea of repurposing vaginal estrogen for skincare might seem appealing, the potential risks outweigh any unproven benefits. “What we need are larger, long-term studies evaluating safety, dosing and cancer risk before any widespread recommendation could be made,” Agbai concludes.
Disclaimer: This article provides general medical information and should not be considered a substitute for professional medical advice. Always consult with a qualified healthcare provider for any health concerns or before making any decisions related to your health or treatment.
The FDA continues to monitor reports of adverse events related to off-label drug use. Consumers are encouraged to report any negative side effects to the FDA’s MedWatch program. The next step in understanding the potential risks of this trend will likely involve further research into the systemic absorption rates of vaginal estrogen when applied to different areas of the body.
Have you encountered this trend online? Share your thoughts and experiences in the comments below, and please share this article with anyone you know who might be considering this practice.
